Craig’s Cause Pancreatic Cancer Society

• Advocates push province to fund pancreatic cancer drug as surge in late-stage diagnoses predicted

  The renewed push for Onivyde comes as experts predict a surge in late-stage cancer diagnoses due to a lack of cancer screening and services during the COVID-19 pandemic.

  Health

  Mar 5, 2021
  
• Pancreatic cancer survivor, advocates renew call for life-sustaining drug not available in Canada

  The life-sustaining drug Onivyde was approved by Health Canada in 2017, but negotiations to distribute throughout the country ended two years later.

  Health

  Nov 19, 2020
  
• Advertisement
• New Brunswick’s annual walk for pancreatic cancer goes virtual

  Only around eight per cent of Canadians diagnosed with pancreatic cancer will live for five or more years after diagnosis.

  Health

  Oct 25, 2020